• Call Us! 786.749.1221

  • NASDAQ: SMFL $2.29

Press Release

Smart for Life Executes Strategic Agreement with CloudKitchens for Rapid Local Delivery of its High Protein Ice Cream Across Major US Markets
Smart for Life Executes Strategic Agreement with CloudKitchens for Rapid Local Delivery of its High Protein Ice Cream Across Major US Markets 1920 1080 Smart for Life, Inc.

Partnership with CloudKitchens Provides Delivery of the Company’s Ice Cream Products through Services Such as UberEats, GrubHub and DoorDash

Initial Launch Markets to Include New York, Miami and Los Angeles

Miami, FL – May 17, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it has executed a strategic agreement with CloudKitchens for rapid local delivery of its new line of innovative, proprietary and healthy high protein ice cream bars.

The partnership with CloudKitchens will enable delivery of the Company’s ice cream bars through services such as UberEats, GrubHub and DoorDash across major markets in the US, with an initial focus on New York, Miami and Los Angeles. CloudKitchens is a leading provider of “ghost kitchens” for restaurant delivery and pickup.

“We are excited to partner with CloudKitchens to accelerate the nationwide rollout of our new, proprietary line of innovative, high protein ice cream,” stated Darren Minton, Smart for Life’s Chief Executive Officer. “We launched this new functional food product category last month and believe it has tremendous growth potential. With CloudKitchens, we will now be able to reach millions of new customers with on-demand, direct-to-consumer delivery and pickup. We will also have access to state-of-the-art delivery hubs, order fulfillment services and top-notch sales and inventory software. We believe we are pioneering a new concept in frozen foods as our line of protein ice cream bars are formulated to be high in protein, high in fiber, and provide sustained energy, all with a delicious taste in a completely novel form factor. We will initiate our launch with target markets in New York, Miami and Los Angles and look forward to customers trying our delicious ice-cream flavors in Vanilla-Chocolate, Cookies & Cream, and Strawberry.”

Smart for Life’s high protein ice cream bars will be available in select markets and online. To learn more about Smart for Life’s innovative new line of protein-based ice cream products please visit: www.icecreamprotein.com.

About CloudKitchens
CloudKitchens is the developer of infrastructure and software that enables food operators to open delivery-only locations with minimal capital expenditure and time.  CloudKitchens was founded to provide its expertise to the fast-growing “ghost kitchen” market, leveraging its assets and technology that are optimized for speed, quality, and scale, making it easy to launch a new delivery restaurant or sales channel. CloudKitchens also enable existing restauranteurs and online brands to expand the reach of their current restaurant location or concept into its established network of locations across major metropolitan areas in the United States. A growing list of restaurants and brands use CloudKitchens as an experimental space, optimizing staff and inventory while testing new ideas.  The company was founded by Diego Berdakin, with significant investors including Uber’s founder Travis Kalanick and Microsoft. For more information, please visit: www.cloudkitchens.com.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

The company’s previously issued letter to shareholders is available at: www.smartforlifecorp.com/2023/01/12/smart-for-life-ceo-issues-year-end-letter-to-shareholders/.

The Company recently released a video report from A.J. Cervantes, Jr., the Company’s Chairman.   That report can be accessed here: https://smartforlifecorp.com/2023/04/02/chairmans-video-report/

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

BACK TO NEWSROOM

Smart for Life Announces Closing of $900,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Smart for Life Announces Closing of $900,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules 1920 1080 Smart for Life, Inc.

Miami, FL – May 2, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it has closed its previously announced registered direct offering with a single institutional investor for the purchase and sale of 280,601 shares of the Company’s common stock (or common stock equivalents) at a purchase price of $3.205 per share of common stock priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company issued to the investor unregistered common stock purchase warrants (the “Warrants”). The Warrants to purchase up to 280,601 shares of common stock have an exercise price of $3.08 per share and are immediately exercisable for a period of five and one-half years following issuance.

H.C. Wainwright & Co. acted as the exclusive placement agent for the offerings.

The gross proceeds to the Company from these offerings were approximately $900,000, before deducting the placement agent’s fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from these offerings for working capital and other general corporate purposes.

The shares of common stock (and common stock equivalents) described above were offered by the Company pursuant to a “shelf” registration statement on Form S-3 (File No. 333-271052) previously filed with the Securities and Exchange Commission (the “SEC”) and declared effective by the SEC on April 10, 2023. The offering of the shares of common stock (and common stock equivalents) were made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A final prospectus supplement and accompanying prospectus relating to the registered direct offering was filed with the SEC. Electronic copies of the final prospectus supplement and accompanying prospectus may be obtained on the SEC’s website at http://www.sec.gov or by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (212) 865-5711 or e-mail at placements@hcwco.com.

The Warrants described above were issued in a concurrent private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Regulation D promulgated thereunder and, along with the shares of common stock underlying the Warrants, have not been registered under the Securities Act, or applicable state securities laws. Accordingly, the Warrants and underlying shares of common stock may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

BACK TO NEWSROOM

Smart for Life Announces $900,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Smart for Life Announces $900,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules 1920 1080 Smart for Life, Inc.

Miami, FL – May 2, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it has entered into a definitive agreement with a single institutional investor for the purchase and sale of 280,601 shares of the Company’s common stock (or common stock equivalents) at a purchase price of $3.205 per share of common stock in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue to the investor unregistered common stock purchase warrants (the “Warrants”). The Warrants to purchase up to 280,601 shares of common stock have an exercise price of $3.08 per share and are immediately exercisable for a period of five and one-half years following issuance. The closing of the registered direct offering and the concurrent private placement is expected to occur on or about May 5, 2023, subject to the satisfaction of customary closing conditions.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offerings.

The gross proceeds to the Company from these offerings are expected to be approximately $900,000, before deducting the placement agent’s fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from these offerings for working capital and other general corporate purposes.

The shares of common stock (and common stock equivalents) described above are being offered by the Company pursuant to a “shelf” registration statement on Form S-3 (File No. 333-271052) previously filed with the Securities and Exchange Commission (the “SEC”) and declared effective by the SEC on April 10, 2023. The offering of the shares of common stock (and common stock equivalents) is made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A final prospectus supplement and accompanying prospectus relating to the registered direct offering will be filed with the SEC. Electronic copies of the final prospectus supplement and accompanying prospectus may be obtained, when available, on the SEC’s website at http://www.sec.gov or by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (212) 865-5711 or e-mail at placements@hcwco.com.

The Warrants described above are being issued in a concurrent private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Regulation D promulgated thereunder and, along with the shares of common stock underlying the Warrants, have not been registered under the Securities Act, or applicable state securities laws. Accordingly, the Warrants and underlying shares of common stock may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

BACK TO NEWSROOM

Smart for Life Announces Planned Launch of Greens First Children’s Chewable Multivitamins in Q2 2023
Smart for Life Announces Planned Launch of Greens First Children’s Chewable Multivitamins in Q2 2023 1920 1080 Smart for Life, Inc.

New Line of Children’s Chewable Multivitamin Formulated with Bioavailable Vitamins for Better Absorption

Contains No Sugar or Artificial Sweeteners and is Easy to Chew and Easy to Swallow

Miami, FL – May 2, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it is launching a line of Greens First Children’s Chewable Multivitamins.

These children’s chewable multivitamins represent a new product offering for the Greens First brand. The chewable multivitamins offer 5 tasty fruit flavors that contain bioavailable vitamins, no artificial colors or preservatives and are a safe and healthy way to help ensure children get the nutrients they need every day.

“Growing up healthy and strong requires the right balance of nutrients, but getting them all from food can be challenging. That’s why we created Greens First Children’s Chewable Multivitamins, which are specially formulated to provide the nourishment a growing child needs,” stated Ryan Benson, CEO of Ceautamed Worldwide. “Each yummy tablet contains a blend of essential vitamins, minerals, and antioxidants that support your child’s overall health and wellbeing. From bones and teeth to the brain and immune system, our multivitamins help fill the nutritional gaps common in children’s diets to support healthy growth and development.”

“We are excited to launch this new product line of Greens First children’s chewable multivitamins,” stated Darren Minton, Smart for Life’s Chief Executive Officer. “Greens First developed this line because parents were looking for a high-quality children’s multivitamin from a brand they can trust that has clean ingredients. Unfortunately, kids these days are not getting the proper nutrients they need from their diets due to modern farming practices and processed foods. A high-quality multivitamin can provide optimal levels of essential nutrients to bridge that nutritional gap. We look forward to bringing these tasty, fun and easy chewables to market that we believe will have kids looking forward to taking their vitamins.”

The new line of Greens First Children’s Chewable Multivitamins is expected to be available in the second quarter of 2023. To learn more about the various products offered under the Greens First line of vitamins and supplements, please visit: www.greensfirst.com.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

The company’s previously issued letter to shareholders is available at: www.smartforlifecorp.com/2023/01/12/smart-for-life-ceo-issues-year-end-letter-to-shareholders/.

The Company recently released a video report from A.J. Cervantes, Jr., the Company’s Chairman.   That report can be accessed here: https://smartforlifecorp.com/2023/04/02/chairmans-video-report/

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

BACK TO NEWSROOM

Smart for Life Releases Video Showcasing New High Protein Ice Cream
Smart for Life Releases Video Showcasing New High Protein Ice Cream 1920 1080 Smart for Life, Inc.

Dr. Sasson Moulavi Discusses Benefits of Smart for Life’s
Unique New Product Category

Miami, FL – April 26, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it has released a video showcasing the benefits of the Company’s new high protein ice cream. The video interview features Dr. Sasson E. Moulavi (Dr. Sass), Chief Medical Officer of Smart for Life and developer of the R&D initiatives behind the Company’s innovative high protein ice cream products.

“Fueled by my background in the field of medicine and my own weight loss journey, I have spent the bulk of my professional career addressing weight loss issues and developing clinically proven products at Smart for Life that are balanced, nutritious and healthy,” stated Dr. Sass. “Having conducted extensive R&D development for the past 3 years, I am pleased to unveil our new proprietary ice cream bars that are packed with high-quality protein, fiber, and essential nutrients. This formula also helps to regulate blood sugar levels, reducing risk of insulin resistance and type 2 diabetes. I believe our high protein ice cream bars represent an entirely new category, and I’m excited to extoll their benefits as we expand our launch in local markets across the nation.”

Smart for Life’s video featuring Dr. Sasson Moulavi can be found here:
www.smartforlifecorp.com/2023/04/20/dr-sass-protein-ice-cream

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

The company’s previously issued letter to shareholders is available at: www.smartforlifecorp.com/2023/01/12/smart-for-life-ceo-issues-year-end-letter-to-shareholders/.

The Company recently released a video report from A.J. Cervantes, Jr., the Company’s Chairman.   That report can be accessed here: https://smartforlifecorp.com/2023/04/02/chairmans-video-report/

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

BACK TO NEWSROOM

Smart for Life Launches Proprietary New Line of High Protein Ice Cream
Smart for Life Launches Proprietary New Line of High Protein Ice Cream 1920 1080 Smart for Life, Inc.

Category-Defining Next Generation Ice Cream Formulas High in Protein and Fiber, Providing Sustained Energy on the Go

Campaign Theme: “This Body Eats Ice Cream!”

Miami, FL – April 25, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it is launching an innovative line of proprietary and healthy high protein ice cream bars, representing a completely new functional food product category for the Company. The R&D initiatives behind the products were spearheaded by Dr. Sasson E. Moulavi (Dr. Sass), Chief Medical Officer of Smart for Life.

Smart for Life’s category-defining new line of protein ice cream bars is formulated to be high in protein, high in fiber, and provide sustained energy, all with a delicious taste in a completely novel form factor that we believe is one of a kind. This ratio of protein, fiber and other nutrients in an ice cream bar format is completely novel and represents what we believe to be a pioneering new concept in frozen foods.

“Smart for Life has created a totally new and unique type of gourmet, high protein, high fiber ice cream bar that is healthy, nutritious and, most of all, delicious,” said Darren Minton, Smart for Life’s Chief Executive Officer. “Our specialist formulations team, led by Dr. Sass, a bariatric specialist with over 15 years of experience in healthy foods, has developed a truly differentiated product category for our Company that we believe people are going to love. The all natural blend of functional ingredients in Smart for Life’s high protein ice cream products provide sustained energy throughout the day, preventing energy crashes and helping to maintain focus and productivity.”

Initial flavors include Vanilla-Chocolate, Cookies & Cream, and Strawberry, with additional varieties expected to join the line-up after feedback is received from launch testing in select markets.

“The R&D process for the creation of our new, proprietary line of innovative, high protein ice cream bars has been an intensive, multi-year labor of love,” said Dr. Sass. Our functional ice cream bars are packed with high-quality protein, fiber, and essential nutrients that support muscle recovery, health management, and healthy digestion, while helping to regulate blood sugar levels, thereby reducing the risk of insulin resistance and type 2 diabetes. Not only can our new high protein ice cream bars potentially improve overall health and wellbeing, but they also taste fantastic! High protein ice cream is a perfect addition to our top-quality product line of nutritious cookies, supplements, shakes, bars and soups – all of which are designed to help our customers enjoy discovering the healthiest version of themselves.”

According to Fortune Business Insights, the global ice cream market is projected to grow from $73.61 billion in 2022 to $104.96 billion by 2029, at a CAGR of 5.20%. Additionally, the rise of health consciousness amongst consumers is also expected to fuel the demand for premium ice creams in the upcoming years.

“Smart for Life believes the demand for this innovative new line of functional and delicious ice cream products will be significant, especially after consumers try them for the first time,” concluded Mr. Minton.  “We plan to launch a variety of flavors in local markets and look forward to providing exciting updates in the near future.”

Smart for Life’s high protein ice cream bars will be available in select markets and online. To learn more about Smart for Life’s innovative new line of protein-based ice cream products please visit: www.icecreamprotein.com.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

The company’s previously issued letter to shareholders is available at: www.smartforlifecorp.com/2023/01/12/smart-for-life-ceo-issues-year-end-letter-to-shareholders/.

The Company recently released a video report from A.J. Cervantes, Jr., the Company’s Chairman.   That report can be accessed here: https://smartforlifecorp.com/2023/04/02/chairmans-video-report/

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

BACK TO NEWSROOM

Smart for Life to Participate in MicroCap Rodeo’s ‘Lassoing the Big Apple’ Conference May 16-17
Smart for Life to Participate in MicroCap Rodeo’s ‘Lassoing the Big Apple’ Conference May 16-17 1920 1080 Smart for Life, Inc.

Conference Represents Initiation of Enhanced Outreach Activities to Increase Awareness

Miami, FL – April 24, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it has been invited to present at MicroCap Rodeo’s Lassoing the Big Apple conference, which is being held on May 16-17, 2023, at the New York Hilton Midtown.

Management will also host one-on-one meetings with qualified investors throughout the conference. To receive additional information, request an invitation or to schedule a one-on-one meeting, please email smfl@crescendo-ir.com.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

The company’s previously issued letter to shareholders is available at: www.smartforlifecorp.com/2023/01/12/smart-for-life-ceo-issues-year-end-letter-to-shareholders/.

The Company recently released a video report from A.J. Cervantes, Jr., the Company’s Chairman.   That report can be accessed here: https://smartforlifecorp.com/2023/04/02/chairmans-video-report/

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

BACK TO NEWSROOM

Smart for Life Announces Reverse Stock Split
Smart for Life Announces Reverse Stock Split 1920 1080 Smart for Life, Inc.

Stock Split is a Key Element of Company’s Strategic Initiatives as It Prepares for Next Generation of Its Acquisition Financings

Miami, FL – April 21, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, announced that it will effect a 1-for-50 reverse stock split (“reverse split”) of its common stock, par value $0.0001 per share (“common stock”), that will become effective on April 24, 2023. Smart for Life’s common stock will continue to trade on The Nasdaq Capital Market (“Nasdaq”) under the symbol “SMFL” and will begin trading on a split-adjusted basis when the market opens on April 24, 2023. The new CUSIP number for the Common Stock following the reverse split will be 83204U301.

Among other considerations, the reverse split is intended to bring the Company into compliance with the minimum bid price requirement for maintaining the listing of its common stock on the NASDAQ Capital Market and to make the bid price more attractive to investors. In addition, the split is part of a larger strategic plan to support future acquisition financings, including multiple accretive acquisitions currently and prospectively in the Company’s pipeline.

“Across the tumultuous conditions in the global markets, it is no secret that public companies of all sizes have seen significant diminution of their market values over the last year,” stated Darren Minton, Smart for Life’s Chief Executive Officer. “As we have previously mentioned since first announcing our plans to regain Nasdaq compliance late last year, this strategic restructuring as part of the Company’s capitalization acknowledges that reality and better positions the Company for our serial accretive acquisitions going forward.”

Mr. Minton concluded, “We want to reaffirm our publicly stated plans of growing to over $100 million in annualized revenues in the next twelve months based on anticipated acquisitions in our pipeline. This is in addition to achieving $300 million in revenues by 2026. We encourage everyone following our company to stay tuned as we enter this next phase of our strategic growth.”

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

The company’s previously issued letter to shareholders is available at: www.smartforlifecorp.com/2023/01/12/smart-for-life-ceo-issues-year-end-letter-to-shareholders/.

The Company recently released a video report from A.J. Cervantes, Jr., the Company’s Chairman.   That report can be accessed here: https://smartforlifecorp.com/2023/04/02/chairmans-video-report/

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

BACK TO NEWSROOM

Smart for Life Provides Update on Pending Acquisition
Smart for Life Provides Update on Pending Acquisition 1920 1080 Smart for Life, Inc.

Anticipated Closing within the Next 30 Days

Acquisition Expected to Contribute in Excess of $10 Million of Revenue and Accretive to Earnings

Miami, FL – April 17, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today provided a business update on the previously announced pending acquisition.

This acquisition target is currently generating estimated revenue in excess of $10 million and over $2 million of EBITDA for the trailing twelve months. The acquisition is a validation of the Company’s Buy-and-Build strategy designed to establish Smart for Life as a major international force in the Health & Wellness sector.

“We are excited to announce that internal due diligence has been concluded and we are finalizing the formal audit for the planned acquisition,” stated Darren Minton, the Chief Executive Officer of Smart for Life. “In addition, we expect definitive agreements, including the Stock Purchase Agreement, Seller Notes and Employment Agreement will be executed shortly. Upon closing, this would be our largest and most profitable acquisition to date, and we look forward to integrating this brand into our exciting family of products.”

The Company also noted that a material economic benefit of the acquisition is the immediate migration of the acquisition’s contract manufacturing business to the Company’s Bonne Santé Natural Manufacturing facility in Miami. The acquisition’s contract manufacturing expenditures are currently in excess of $5 million annually. A video regarding the Company’s manufacturing facility is available at: www.bonnesantemanufacturing.com/video.

Mr. Minton concluded, “This transaction is another building block in our family of brands as we move toward our previously stated mission of $100 million in annualized revenues in 2023.”

“On completion of the acquisition, the Company anticipates launching a robust investor and public awareness program utilizing a broad array of communications tools,” stated A.J. Cervantes, Jr. Chairman of Smart for Life.

Completion of the acquisition is subject to a number of conditions including finalization of the audit and financing.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues by the fourth quarter of 2026. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

The company’s previously issued letter to shareholders is available at: www.smartforlifecorp.com/2023/01/12/smart-for-life-ceo-issues-year-end-letter-to-shareholders/.

The Company recently released a video report from A.J. Cervantes, Jr., the Company’s Chairman.   That report can be accessed here: https://smartforlifecorp.com/2023/04/02/chairmans-video-report/

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

BACK TO NEWSROOM

Smart for Life Releases High Impact TV Commercial
Smart for Life Releases High Impact TV Commercial 2120 1192 Smart for Life, Inc.

Production Highlights Company’s Broad Array of Brands and Products; Planned National Network Distribution Intended to Drive Consumer and Market Awareness

Miami, FL – April 11, 2023 – Globe Newswire – Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a high growth global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced the release of a recently produced commercial intended for broadcast via multiple television and online networks.

“Our first national TV commercial was expressly created to introduce Smart for Life’s exciting brands and products to a broad audience of consumers and potential investors,” said Darren Minton, Smart for Life’s Chief Executive Officer. “Viewers will get an opportunity to see Smart for Life’s ever-expanding line of products, including vitamins, supplements, sports nutrition offerings, health bars and functional foods. The Smart for Life story is especially relevant with the vast number of people looking for ways to enhance and maintain their health in a post-Covid world. We look forward to increasing our awareness to a much wider audience as we expand our reach across the United States and around the world.”

The commercial can be found at the Company’s new media-focused website, www.smfl.tv.

The commercial was produced by Corvus & Coil, a national agency offering a broad range of marketing, branding, and communications services, principally for early-stage public companies.

About Corvus & Coil LLC
With more than 25 years of experience and over 200 public company client engagements, Corvus & Coil’s principals are uniquely equipped to deliver world-class integrated branding, marketing, and communications solutions that command attention and deliver measurable results. For more information regarding Corvus & Coil, please visit www.corvuscoil.com.

About Smart for Life, Inc.
Smart for Life, Inc. (Nasdaq: SMFL) is engaged in the development, marketing, manufacturing, acquisition, operation and sale of a broad spectrum of nutritional and related products with an emphasis on health and wellness. Structured as a publicly held global holding company, the Company is executing a Buy-and-Build strategy with serial accretive acquisitions creating a vertically integrated company with an objective of aggregating companies generating a minimum of $300 million in revenues within the next thirty-nine months. To drive growth and earnings, Smart for Life is developing proprietary products as well as acquiring other profitable companies, encompassing brands, manufacturing and distribution channels. The Company currently operates five subsidiaries including Doctors Scientific Organica, Nexus Offers, Bonne Santé Natural Manufacturing, GSP Nutrition and Ceautamed Worldwide. For more information about Smart for Life, please visit: www.smartforlifecorp.com.

Video regarding the Company’s manufacturing facility at Bonne Santé Natural Manufacturing is available at: www.bonnesantemanufacturing.com/video.

Investor material and a Fact Sheet with additional information about Smart for Life is available at: www.smartforlifecorp.com/investor-center.

The company’s previously issued letter to shareholders is available at: www.smartforlifecorp.com/2023/01/12/smart-for-life-ceo-issues-year-end-letter-to-shareholders/.

Forward-Looking Statements
This press release may contain information about our views of future expectations, plans and prospects that constitute forward-looking statements. All forward-looking statements are based on management’s beliefs, assumptions and expectations of Smart for Life’s future economic performance, taking into account the information currently available to it. These statements are not statements of historical fact. Although Smart for Life believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Smart for Life does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law. No assurances can be made that Smart for Life will successfully acquire its acquisition targets. Forward-looking statements are subject to a number of factors, risks and uncertainties, some of which are not currently known to us, that may cause Smart for Life’s actual results, performance or financial condition to be materially different from the expectations of future results, performance or financial position. Actual results may differ materially from the expectations discussed in forward-looking statements. Factors that could cause actual results to differ materially from expectations include general industry considerations, regulatory changes, changes in local or national economic conditions and other risks set forth in “Risk Factors” included in our filings with the Securities and Exchange Commission.

Disclaimer
The information provided in this press release is intended for general knowledge only and is not a substitute for professional medical advice or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure or prevent any disease.

Investor Relations Contact
Crescendo Communications, LLC
Tel: (212) 671-1021
SMFL@crescendo-ir.com

BACK TO NEWSROOM
Enter your
text here